Introduction Understanding the intricacies of biosimilars is essential in today’s healthcare landscape, where these biological products are increasingly recognized for their potential to enhance...
<h2 id="introduction">Introduction</h2> <p>Understanding the intricacies of biosimilars is essential in today’s healthcare landscape, where these biological products are increasingly recognized for their potential to enhance patient access to effective treatments. As biosimilars gain traction, the concept of interchangeability—where a biosimilar can be substituted for its reference product without prescriber intervention—emerges as a pivotal focus for healthcare providers and patients alike. However, the journey toward embracing biosimilars is fraught with challenges. Stakeholders must navigate the complexities of regulatory frameworks and clinical implications to fully leverage the benefits of these innovative therapies.</p> <p>How can we ensure that the transition to biosimilars is as seamless as possible for all involved?</p> <h2 id="define-biosimilars-and-interchangeability">Define Biosimilars and Inte…